Kessler H - Search Results

1

Ligands for mapping alphavbeta3-integrin expression in vivo.

Schottelius M, Laufer B, Kessler H, Wester HJ. Schottelius M, et al. Among authors: kessler h. Acc Chem Res. 2009 Jul 21;42(7):969-80. doi: 10.1021/ar800243b. Acc Chem Res. 2009. PMID: 19489579

2

Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting.

Haubner R, Wester HJ, Reuning U, Senekowitsch-Schmidtke R, Diefenbach B, Kessler H, Stöcklin G, Schwaiger M. Haubner R, et al. Among authors: kessler h. J Nucl Med. 1999 Jun;40(6):1061-71. J Nucl Med. 1999. PMID: 10452325 Free article.

3

Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.

Haubner R, Wester HJ, Burkhart F, Senekowitsch-Schmidtke R, Weber W, Goodman SL, Kessler H, Schwaiger M. Haubner R, et al. Among authors: kessler h. J Nucl Med. 2001 Feb;42(2):326-36. J Nucl Med. 2001. PMID: 11216533 Free article.

4

Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography.

Haubner R, Wester HJ, Weber WA, Mang C, Ziegler SI, Goodman SL, Senekowitsch-Schmidtke R, Kessler H, Schwaiger M. Haubner R, et al. Among authors: kessler h. Cancer Res. 2001 Mar 1;61(5):1781-5. Cancer Res. 2001. PMID: 11280722

5

Docking studies on alphavbeta3 integrin ligands: pharmacophore refinement and implications for drug design.

Marinelli L, Lavecchia A, Gottschalk KE, Novellino E, Kessler H. Marinelli L, et al. Among authors: kessler h. J Med Chem. 2003 Oct 9;46(21):4393-404. doi: 10.1021/jm020577m. J Med Chem. 2003. PMID: 14521404

6

[18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates.

Haubner R, Kuhnast B, Mang C, Weber WA, Kessler H, Wester HJ, Schwaiger M. Haubner R, et al. Among authors: kessler h. Bioconjug Chem. 2004 Jan-Feb;15(1):61-9. doi: 10.1021/bc034170n. Bioconjug Chem. 2004. PMID: 14733584

7

Synthesis and biological evaluation of a (99m)Tc-labelled cyclic RGD peptide for imaging the alphavbeta3 expression.

Haubner R, Bruchertseifer F, Bock M, Kessler H, Schwaiger M, Wester HJ. Haubner R, et al. Among authors: kessler h. Nuklearmedizin. 2004 Feb;43(1):26-32. doi: 10.1267/nukl04010026. Nuklearmedizin. 2004. PMID: 14978538

8

Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and octreotide analogs.

Poethko T, Schottelius M, Thumshirn G, Hersel U, Herz M, Henriksen G, Kessler H, Schwaiger M, Wester HJ. Poethko T, et al. Among authors: kessler h. J Nucl Med. 2004 May;45(5):892-902. J Nucl Med. 2004. PMID: 15136641 Free article.

9

First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography.

Schottelius M, Poethko T, Herz M, Reubi JC, Kessler H, Schwaiger M, Wester HJ. Schottelius M, et al. Among authors: kessler h. Clin Cancer Res. 2004 Jun 1;10(11):3593-606. doi: 10.1158/1078-0432.CCR-03-0359. Clin Cancer Res. 2004. PMID: 15173065

10

Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD.

Haubner R, Weber WA, Beer AJ, Vabuliene E, Reim D, Sarbia M, Becker KF, Goebel M, Hein R, Wester HJ, Kessler H, Schwaiger M. Haubner R, et al. Among authors: kessler h. PLoS Med. 2005 Mar;2(3):e70. doi: 10.1371/journal.pmed.0020070. Epub 2005 Mar 29. PLoS Med. 2005. PMID: 15783258 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,227 results

Search Page

Filters